Revolutionise Your Research with Axtria Rapid CSR for Faster, More Accurate Clinical Study Reports
Clinical study reports (CSRs) provide comprehensive summaries of clinical trials, detailing the critical elements of study design, endpoints, methodologies, results, and conclusions. The creation of CSRs involves 16 distinct sections, requiring months of collaboration among various stakeholders who must analyze vast amounts of complex study data to develop customized summaries. We can now do this better, faster, and more efficiently —we are announcing a bold, new breakthrough in the CSR authoring process: Axtria Rapid CSR. This innovative solution is predicated on a multi-LLM approach capable of automating the creation of even the most comprehensive CSRs’ first draft. The result? About 30-50% faster report authoring, with 90% accuracy. And yes, it’s perfectly aligned with strict ICH-E3 standards. Axtria Rapid CSR has been extensively trained and tested and easily supports studies of all sizes, from early-phase trials to large-scale phase III trials and post-market surveillance. Watch this short demo of how simple it is to use Axtria Rapid CSR. The solution not only automates—it’s also smart. Axtria Rapid CSR draws critical inferences from multiple study data inputs, providing deeper context and relevance, even for the most complex sections of a report. With it, we’ve seen significant advances in our ability to generate accurate medical writing, particularly in safety and efficacy. This is a stroke of genius from our Clinical Solutions team. We believe CSR authoring will never be the same. Axtria Rapid CSR combines the power of artificial intelligence with human expertise to deliver superior results. It eliminates the tedious efforts of clinical researchers and medical writers, giving them the freedom to spend their time searching for revelations, not repetition. A 30-50% faster turnaround means substantial cost savings for life sciences companies. Better accuracy can mean quicker regulatory approvals. And that helps get the latest life-changing medications to the patients who need them most—at the right time. Contact us at axtria_clinicalsolutions@axtria.com for a one-on-one demonstration and check out how Axtria Rapid CSR modernizes your clinical study report process, allowing for faster approvals, cutting costs, and improving more lives. Axtria works with 16 of the top 20 life science companies globally. In addition to Rapid CSR, Axtria’s years of domain experience in the industry guide pharma clients from brand launches to retirement. Their products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimise field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next best action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.
Axtria’s groundbreaking new offering delivers CSRs 30-50% faster with 90% accuracy, cutting errors and costly manual efforts.
Axtria’s groundbreaking new offering delivers CSRs 30-50% faster with 90% accuracy, cutting errors and costly manual efforts.
["axtria", "Axtria Rapid CSR", "Clinical Study Reports", "clinical trials", "cost savings", "life sciences companies", "life-changing medications"]
["Go", "API", "artificial intelligence", "life-changing medications", "AWS", "AI", "cloud_platforms:AWS", "axtria", "programming_languages:R", "programming_languages:Go", "cost savings", "RAG", "Clinical Study Reports", "Axtria Rapid CSR", "life sciences companies", "clinical trials", "R"]
["AI", "artificial intelligence", "RAG", "AWS", "R", "Go", "API", "cloud_platforms:AWS", "programming_languages:R", "programming_languages:Go"]
Navdeep "Navi" Chadha is an accomplished entrepreneur and co-founder of Axtria, a firm dedicated to delivering data-driven solutions through industry expertise, analytics, and technology. He is a charter member of the NJ-Philly TiE chapter and serves on the boards of various non-profit organizations. 
Navi has been recognized with the Top Industry Leaders Award 2022 by Life Sciences Voice and was named E&amp;Y's Entrepreneur of the Year in 2018. Prior to Axtria, he co-founded marketRx, where he led product development and operations, earning multiple accolades before its acquisition in 2007. Navi is passionate about innovation and market expansion.